Tail Length, % DNA in the Tail, and Tail Moment in the comet assay (Singh et al., 1988; Tice et al., 2000) .
With regard to the interpretation of results, when DNA damage is detected in an organ by treatment with test subattributable to genotoxicity or cytotoxicity. Although there have been many reports on this assay in multiple organs, such as the liver, kidneys, lungs, spleen, and bone marrow etc., comparisons to establish the doses that induce DNA damage or cytotoxicity are limited (Miyamae et al., 1998; Sekihashi et al., 2001) . Methyl methanesulfonate (MMS), an alkylating agent and a genotoxic compound that reacts with DNA directly, has been reported to be positive in a micronucleus study (Hayashi et al., 1989) , and an in vivo/in vitro unscheduled DNA synthesis study (Puri and Müller, 1989) , and is commonly used as a positive control substance in various genotoxicity studies. Acetaminophen (APAP), a widely used analgesic drug, may cause toxic liver injury at overdosing, due to APAP metabolite leading to hepatocyte damage (reviewed by Vermeulen et al., 1992) . It has been reported that APAP showed to not be genotoxic in several in vitro test systems (Dybing et al., 1984; Oldham et al et al., 1981) , and the hepatotoxicity of APAP may be independent of mutagenicity (Westendorf et al., 1984) . However, in rodents in vivo, DNA binding and DNA strand breaks in hepatocytes (Hongslo et al., 1994) and chromosome aberraobserved upon treatment with APAP. Thus, the relation between APAP-induced DNA strand breaks and cytotoxicity is not clear.
In this study, DNA damage potential of MMS, as a in vivo comet assay in multiple organs such as the liver, kidneys and bone marrow in mice. APAP was evaluated for whether APAP induces DNA damage or not, and furthermore, investigated for whether DNA damage is attributable to cytotoxicity or not, by the in vivo comet assay accompanied with blood chemistry.
MATERIALS AND METHODS

Chemicals and treatment
MMS and APAP were purchased from Nacalai tesque Inc. (Japan). Low-melting agarose (LMA), lysis solution, (USA). MMS and APAP were dissolved in saline (Japanese Pharmacopoeia) from Otsuka Pharmaceutical Factory, Inc. (Japan).
Animal experiment
Seven-week-old male Crlj:CD1(ICR) mice (Charles River Japan Inc., Japan) were used. The animals were on individual body weight. The animals were individually housed in stainless-steel cages in an animal room that was lit for 12 hr (8:00-20:00) daily and maintained at 19-was allowed free access to water and a pellet diet (CRF-1, sterilized by radiation, Oriental Yeast Co., Japan).
The mice were intraperitoneally once treated with -were treated with saline. The mice were sacrificed at 4 or 24 hr after treatment. The animals were euthanized by exsanguination under pentobarbital anesthesia after blood sampling, and liver, kidney and bone marrow samples were obtained from each animal immediately after sacri-
The animal experiments were conducted according to the Guidelines for Animal Experiments, Research & Development Division, Toray Industries Inc.
Hematology
In the control and MMS-treated animals, blood samples or bone marrow cells were collected in microtubes containing EDTA-2K or saline respectively for cell count--tion (Hb), hematocrit (Ht), mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCHC), and bone marhematology analyzer (Sysmex K-4500, Sysmex corporation, Japan).
Blood chemistry
tubes containing heparin sodium and centrifuged (approximately 2,000 × g; 15 min; 4°C) to obtain plasma for blood chemistry analysis. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), glucose (Glc), triglyceride (TG), total cholesterol (TCh), phossodium (Na), potassium (K), chloride (Cl), Calcium (Ca), and inorganic phosphorus (P) were measured using an autoanalyzer (Hitachi 7070, Hitachi, Ltd., Japan).
Comet assay
The portions of the liver and kidney were washed in pH 7.5) and minced with a pair of scissors, and homogenized using a potter-type homogenizer (Ikemoto Scientific Technology Co, Ltd., Japan). The cell suspensions were centrifuged at 4°C, 700 × g for 10 min. The supernatants were removed and the cells were re-suspended in the cold buffer. The preparation of bone marrow samples was conducted in the same way as the hematology samples. These cell suspensions were adjusted to 1 × 10 5 (Trevigen Inc., USA) which had been kept at 42°C. The -ted onto Comet Slides TM (Trevigen Inc., USA) and spread in the dark. The slides were immersed in pre-chilled lysis Then, the slides were tapped to remove excess lysis solution and placed in a Coplin jar containing alkaline buffer described by Singh et al. (1988) , for 20 min at room temperature in the dark. Next, the slides were removed from (Trevigen Inc., USA) onto agarose and the presence of comets was examined at × 10 magnification in a fluo-- (Kobayashi et al., 1999; Ohyama et al., 1999) . DNA damage was determined by evaluating the number of cells with comet tails, as indicated by the ratios of the number of comet tails and the number of non-head shapes to the total number of nuclei in more than 100 randomly chosen nuclei for each animal. In the control and MMS treated animals, digital images were scanned into an image analyzer (Comet Analyzer v1.5; Youworks Co., Japan) to compare the result by image analysis with the frequencies of tailed nuclei due to genotoxicity. Tail length, % DNA in the tail, and tail moment were obtained by observing 50 nuclei for each animal. The tail length is the distance from the comet head to the last visible signal in the tail. The percentage of DNA in the tail is calculated from the fraction of DNA in the tail divided by the amount of DNA in the nucleus multiplied by 100. The tail moment, called the Olive tail moment, is the product of the amount of DNA in the tail and the mean distance of migration in the tail (Olive et al., 1990) .
Statistical analysis
All data obtained in this study, including hematology, blood chemistry, and DNA damage were analyzed with the SAS non-clinical package (SAS Institute Japan, Japan).
First, the homogeneity of the variance was tested using homogeneous variance was demonstrated, a one-way analysis was applied. The means were further compared using Dunnett's multiple comparison only when the onevariance was not homogeneous, the Kruskal-Wallis test was applied. Steel's test of means was performed only -ences between groups.
RESULTS
Hematology
The results from the MMS-treated animals are shown in Table 1 . Hematology was evaluated for whether the DNA damage is caused by genotoxicity or cytotoxic myelotoxicity of MMS. At 4 hr after treatment, statistically --dependently in all of the MMS-treated groups, and no obvious changes were noted in the other hematological parameters.
Blood chemistry
The results of the blood chemistry analysis are shown whether the DNA damage is caused by genotoxicity or and APAP. In the MMS-treated animals at 4 hr, statisti--trol group, without an increase in Cre. At 24 hr after treatment, these above changes were reversed, and no obvious 
Comet assay
In the liver, kidneys and bone marrow in the mice treated with MMS and APAP, the frequencies of tailed nuclei (DNA damage), indicated by the ratios of the number of comet tails and the number of non-head shapes to the number of total nuclei in the comet assay are described in Table 4 . In the vehicle control group 4 hr after treatment, the DNA damage ratios in the liver, kidneys and bone respectively. The frequencies in the MMS-treated animals bone marrow). These values showed a statistical significance compared to the vehicle control group. Although increases in the frequency of tailed nuclei induced by the hr was less than that at 4 hr. APAP increased the DNA -ment. The DNA damage in the kidney and bone marrow did not increase in the APAP-treated animals. The tail moment, % DNA in the tail, and tail length in the mice treated with MMS, obtained using automated image analysis software are described in Table 5 . In all the organs in the MMS-treated groups, the three parameters showed a transient increase at 4 hr compared to the vehicle control group, similar to the frequencies of the tailed nuclei. In the vehicle control group at 4 hr, the tail moment, % liver in the MMS-treated groups at 4 hr, the three param- values, except for tail moment, showed a statistical significance when compared with the vehicle control group. In the kidneys and bone marrow, all the parameters increased from the control group were noted in the tail length in the kg.
DISCUSSION
The comet assay has already been used to detect genotoxicity in eukaryote cells, providing dependable doseresponse curves for a number of genotoxic agents (Tice et al., 2000) . This assay, which has been known to be rapid, repetitive and cost effective, was adapted for in vivo studies. In this study, MMS, as a genotoxic compound and APAP, a widely used analgesic drug, in the liver, kidneys and bone marrow of mice, was evaluated by in vivo chemistry.
In the comet assay, we calculated not only the frequency of tailed nuclei (DNA damage), but also the tail moment, the % DNA in the tail, and the tail length using automated image analysis software (Comet Analyzer v1.5). DNA damage in all organs was induced by -ever, hepatotoxic markers, plasma AST and ALT levthat DNA damage might be caused by not only the genotoxicity of MMS, but also the hepatotoxicity of MMS -pound reacts with the more nucleophilic sites on DNA via an SN2 reaction to form alkylated bases (Moffatt et al hepatocytes isolated from rats in collagen sandwich cul--was not concentration-dependent, and the plasma creatinine level showed no marked change. The increase in indicate nephrotoxicity of MMS. Therefore, the DNA damage observed in the kidney was due to the genotoxicity of MMS, not nephrotoxicity. These results were consistent with previous reports in rats and mice (Miyamae et al., 1998; Sekihashi et al., 2001; Hosseinzadeh and Sadeghnia, 2007) . Furthermore, MMS was reported to induce carcinogenesis in the hematopoietic system and lungs of mice (Clapp et al et al., 2005) , and DNA damage in the bone marrow was observed at 4 and 24 hr after treatment with MMS in this study. On the other hand, there have been reports of apoptosis induced by MMS (Fairbairn et al., 1994; Suh et al., to apoptosis, was observed in all MMS treatment groups at 24 hr after treatment. Therefore, it is not clear whether is mostly due to genotoxicity or cytotoxicity. MMS produced positive responses in all three organs at 4 hr after treatment, which was supported by the fact that MMS is rapidly distributed throughout the body of mice and rats (IARC, 1999) . The DNA damage was more severe at 4 hr after treatment than 24 hr. This may indicate that the decrease in DNA damage is due to the following factors; cell turnover, or all of which would have reduced the number of damaged cells. In addition, these factors might inhibit the accumulation of DNA damage, explaining why MMS induced tumors in the brain but not in the liver or et al., 1972), even though the initial amount of DNA damage caused by MMS was simand Swenberg, 1978) . The increases of the three parameters, calculated by automated image analysis showed a similar pattern to that by manual scoring after 4 and 24 hr treatment.
APAP is considered a safe analgesic and antipyretic when dosed properly. However, overdosing of APAP may cause toxic liver injury. Protein arylation and free radias pathways leading to hepatocyte damage (reviewed by Vermeulen et al., 1992) . There have been reports that DNA strand breaks in rat hepatoma cells were induced by the reactive APAP metabolite, N-acetyl-p-benzoquinone in Salmonella typhimurium strains (Dybing et al., 1984) . It is unclear whether DNA damage precedes the onset of overt cytotoxicity or not. In the present study, APAP elevated the frequency of tailed nuclei in the liver 4 and 24 hr after treatment. In the kidney and bone marrow, DNA damage was not observed at either time. APAP induced highest dose only, and DNA damage in the liver increased simultaneously at the dose inducing the hepatotoxicity. Therefore, the hepato-cytotoxicity of APAP might contribute to DNA damage induced at the highest dose.
The results in this study suggest that the in vivo comet assay might be used to detect the DNA damage induced by MMS and the subsequent DNA repair in mouse liver, kidneys and bone marrow, and APAP at the highresults may indicate that the DNA damage by APAP treatment was attributable to the hepato-cytotoxicity, because DNA damage and hepato-cytotoxicity were detected at the same doses.
